In FY2025, Axcelis Technologies experienced a substantial revenue decline of 17.6% and operating income contraction of 43.4%, driven by intensifying competition and U.S. export controls restricting sales to China. The company is leveraging its specialized ion implantation technology, modular assembly processes, and robust patent portfolio to sustain market presence while targeting growth in advanced logic segments and aftermarket services. Capital allocation remains disciplined with notable share repurchases and sustained R&D investment to fuel innovation and margin improvement. Customer concentration and geopolitical complexities present ongoing risks to top-line stability, making monitoring backlog trends and regulatory shifts critical for near-term outlook.